Notify me when Athyrium Opportunities III Co-Invest 1 LP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| BIOR | Biora Therapeutics, Inc. | Common Stock, par value $0.001 per share | 50% | $546,565 | 3,416,032 | Jeffrey A. Ferrell | 24 Mar 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|